Panicos Shangaris, LRCP&SI, MBBCh, BAO, PhD, King’s College London, London, UK, shares some insights into research exploring the possibility of using a novel gene-editing tool to treat sickle cell disease (SCD) in-utero, which may provide an off-the-shelf product for those with a fetus affected by SCD. This interview took place at the 63rd Annual Scientific Meeting of the British Society for Haematology (BSH) 2023, held in Birmingham, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.